Pfizer obtains regulatory approvals for $43bn Seagen acquisition
In conjunction with the proposed merger, Pfizer will make amendments to its commercial organisation and enhance focus and performance quality.
13 December 2023
13 December 2023
In conjunction with the proposed merger, Pfizer will make amendments to its commercial organisation and enhance focus and performance quality.
Icosavax develops vaccines for infectious diseases, utilising its protein virus-like particle platform technology.
The application is based on positive data from the Phase III clinical trial of GSK’s RSV vaccine in adults aged 50-59.
The FDA has set a Prescription Drug User Fee Act (PDUFA) date for odronextamab in diffuse large B-cell lymphoma and follicular lymphoma on 31 March 2024.
The license of Maze’s GYS1 program, including MZE001, was the subject of FTC opposition, leading to Sanofi terminating the agreement
Iptacopan met the primary endpoint in the Phase III trial as a treatment for the rare complement-mediated kidney disease C3 glomerulopathy.
The funding will advance Bicara’s lead candidate BCA101, with the EGFR/TGF-β inhibitor currently being evaluated in Phase II clinical trials.
The sale, which will see Aditxt take on Evofem’s debt, follows a strategic review by the women’s health company earlier this year.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Only a handful of approved therapeutic drugs are currently available for the treatment of ARF, all belonging to the solute carrier family 12 member 1 inhibitor. The clinical trial space in ARF consists of almost an equal mix of commercial as well as academic sponsors, with Iran and the US emerging as the key countries for conducting Phase III trials.
Give your business an edge with our leading industry insights.